verified SJR 0,459 · Q3 • database Scopus / SJR & Web of Science indexed

United Kingdom · Taylor and Francis Ltd.

workspace_premium Q3 — Medicine (miscellaneous) lock Subscription

Personalized Medicine

Personalized Medicine is a journal indexed in SJR in Medicine (miscellaneous) and Pharmacology with an H index of 38. It has a price of 2040 €. It has an SJR impact factor of 0,459 and it has a best quartile of Q3. It has an SJR impact factor of 0,459.

ISSN: 1741-0541

Publisher: Taylor and Francis Ltd.

Category: Medicine (miscellaneous)

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,459 Q3

H-index 38

Acceptance rate pie_chart

35%

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

2.040 € Subscription

Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,459

H-index

Docs (year)

Docs 3y

151

Total refs

1920

Cites 3y

245

Citable 3y

145

Cites/Doc 2y

1.74

Ref/Doc

48.0

Immediate OA

2040 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Collaboration as a foundation for advancing research in personalized medicine in cancer care

Your DNA, Your Say': global survey gathering attitudes toward genomics: design, delivery and methods

Genetics of osteoporosis: perspectives for personalized medicine

From pharmacogenomics to integrated personal omics profiling: a gap in implementation into healthcare

Estimation and validation of acenocoumarol dosing algorithms in Bulgarian patients with cardiovascular diseases

Establishing a translational genomics infrastructure in pediatric cancer: the GREAT KIDS experience

Enabling personalized medicine through the use of healthcare information technology

Driving personalized medicine: capturing maximum net present value and optimal return on investment

DNA methylation markers -an opportunity to further individualize therapy in breast cancer?

DNA methylation in personalized medicine

Cytochrome P450 gene-based drug prescribing and factors impacting translation into routine clinical practice

Continuous pharmacogenomics and genomic medicine education for healthcare professionals through electronic educational courses

SHOW MORE ARTICLES

Common polymorphisms in antioxidant genes are associated with diabetic nephropathy in Type 2 diabetes patients

A perspective analysis: companion diagnostics: an evolving paradigm in 21st century healthcare

Challenges and opportunities of pharmacogenetics in drug development

Bridging genomics research between developed and developing countries: the Genomic Medicine Alliance

Breath biomarkers for personalized medicine

Biopharmaceutical industry perspectives on the business prospects for personalized medicine

Biobanking in pediatrics: the human nonsubjects approach

BACE1 levels are increased in plasma of Alzheimer's disease patients compared with matched cognitively healthy controls

Association ofPNPLA3(rs738409 C>G) with liver damage in liver diseases: one step closer to personalized medicine?

Assessment of genetic polymorphisms associated with hyperuricemia or gout in the Hmong

Analysis of insurance preauthorization requests forBRCA1andBRCA2genetic testing: experience of the Humana Genetic Guidance Program

An epidemiology of care approach to lab-on-a-chip systems in individualized medicine?

FAQs

Personalized Medicine has an SJR of 0,459 (best quartile Q3) in the CountryOfPapers database.

Immediate OA APC is 2040 EUR. Non-OA / submission fee is 0 EUR.

The acceptance rate recorded for Personalized Medicine is 35%.

Personalized Medicine

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Personalized Medicine?

What is the APC / publication cost?

What is the acceptance rate?